NASDAQ
SCTL

Societal CDMO Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Societal CDMO Inc Stock Price

Vitals

Today's Low:
$0.93
Today's High:
$0.93
Open Price:
$0.93
52W Low:
$0.38
52W High:
$1.86
Prev. Close:
$0.92
Volume:
396222

Company Statistics

Market Cap.:
$59.71 million
Book Value:
0.603
Revenue TTM:
$89.19 million
Operating Margin TTM:
-3.07%
Gross Profit TTM:
$23.14 million
Profit Margin:
-22.87%
Return on Assets TTM:
-1.13%
Return on Equity TTM:
-44.51%

Company Profile

Societal CDMO Inc had its IPO on 2014-03-07 under the ticker symbol SCTL.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Societal CDMO Inc has a staff strength of 275 employees.

Stock update

Shares of Societal CDMO Inc opened at $0.93 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of $0.93 - $0.93, and closed at $0.93.

This is a +1.09% increase from the previous day's closing price.

A total volume of 396,222 shares were traded at the close of the day’s session.

In the last one week, shares of Societal CDMO Inc have increased by +6.9%.

Societal CDMO Inc's Key Ratios

Societal CDMO Inc has a market cap of $59.71 million, indicating a price to book ratio of 2.1886 and a price to sales ratio of 0.8546.

In the last 12-months Societal CDMO Inc’s revenue was $89.19 million with a gross profit of $23.14 million and an EBITDA of $5.84 million. The EBITDA ratio measures Societal CDMO Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Societal CDMO Inc’s operating margin was -3.07% while its return on assets stood at -1.13% with a return of equity of -44.51%.

In Q2, Societal CDMO Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 5.8%.

Societal CDMO Inc’s PE and PEG Ratio

Forward PE
18.2482
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.3 per share while it has a forward price to earnings multiple of 18.2482 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Societal CDMO Inc’s profitability.

Societal CDMO Inc stock is trading at a EV to sales ratio of 1.9316 and a EV to EBITDA ratio of 19.164. Its price to sales ratio in the trailing 12-months stood at 0.8546.

Societal CDMO Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$148.74 million
Total Liabilities
$19.31 million
Operating Cash Flow
$-2141000.00
Capital Expenditure
$2.14 million
Dividend Payout Ratio
0%

Societal CDMO Inc ended 2024 with $148.74 million in total assets and $0 in total liabilities. Its intangible assets were valued at $148.74 million while shareholder equity stood at $54.32 million.

Societal CDMO Inc ended 2024 with $0 in deferred long-term liabilities, $19.31 million in other current liabilities, 900000.00 in common stock, $-273531000.00 in retained earnings and $41.08 million in goodwill. Its cash balance stood at $4.70 million and cash and short-term investments were $4.70 million. The company’s total short-term debt was $8,241,000 while long-term debt stood at $31.01 million.

Societal CDMO Inc’s total current assets stands at $46.62 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $23.27 million compared to accounts payable of $3.93 million and inventory worth $12.86 million.

In 2024, Societal CDMO Inc's operating cash flow was $-2141000.00 while its capital expenditure stood at $2.14 million.

Comparatively, Societal CDMO Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.93
52-Week High
$1.86
52-Week Low
$0.38
Analyst Target Price
$2.92

Societal CDMO Inc stock is currently trading at $0.93 per share. It touched a 52-week high of $1.86 and a 52-week low of $1.86. Analysts tracking the stock have a 12-month average target price of $2.92.

Its 50-day moving average was $0.78 and 200-day moving average was $0.84 The short ratio stood at 5.96 indicating a short percent outstanding of 0%.

Around 924.8% of the company’s stock are held by insiders while 6333.1% are held by institutions.

Frequently Asked Questions About Societal CDMO Inc

The stock symbol (also called stock or share ticker) of Societal CDMO Inc is SCTL

The IPO of Societal CDMO Inc took place on 2014-03-07

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$28.14
-0.03
-0.11%
$1.79
-0.11
-5.79%
$38.97
1.02
+2.69%
$21.04
-0.05
-0.24%
$433.2
-17.1
-3.8%
eMudhra Limited (EMUDHRA)
$470
-22.7
-4.61%
$21.55
1
+4.87%
$0.08
0.07
+716.33%
I-Mab (IMAB)
$1.59
0.06
+3.92%
$132.2
-11.35
-7.91%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

Address

1 E. Uwchlan Ave, Exton, PA, United States, 19341